Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Moleculin Biotech, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2022
- Shares held
- 2.98M
- +21.8K (+0.7%) vs. Q1 2022
- Total value
- $4.32M
- −$943.1K (−17.9%) vs. Q1 2022
- New holders
- 5
- 4 more added
- Sold out
- 2
- 9 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,079,522 | $1.56M | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 1,036,853 | $1.50M | 0.59% | −3,676−0.4% | Reduced |
| BlackRock Inc. | 265,045 | $384.0K | 0.00% | −270−0.1% | Reduced |
| Geode Capital Management, LLC | 247,051 | $358.0K | 0.00% | +1,439+0.6% | Added |
| Renaissance Technologies LLC | 88,100 | $128.0K | 0.00% | +28,200+47.1% | Added |
| State Street Corp | 71,397 | $104.0K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 57,500 | $83.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 46,327 | $67.0K | 0.00% | −4,404−8.7% | Reduced |
| Charles Schwab Investment Management Inc | 31,454 | $46.0K | 0.00% | +11,256+55.7% | Added |
| Jmac Enterprises LLC | 13,132 | $19.0K | 0.00% | +13,132 | New |
| Two Sigma Advisers, LP | 11,700 | $17.0K | 0.00% | −12,500−51.7% | Reduced |
| Bank of America Corp | 6,667 | $10.0K | 0.00% | +17+0.3% | Added |
| Morgan Stanley | 6,000 | $9.00K | 0.00% | −25−0.4% | Reduced |
| Tower Research Capital LLC (TRC) | 4,180 | $6.00K | 0.00% | −11−0.3% | Reduced |
| Advisor Group Holdings, Inc. | 3,952 | $6.00K | 0.00% | −281−6.6% | Reduced |
| Urban Wealth Management, LLC | 3,019 | $4.00K | 0.01% | +3,019 | New |
| Rockefeller Capital Management L.P. | 1,792 | $2.00K | 0.00% | −985−35.5% | Reduced |
| UBS Group AG | 1,653 | $2.00K | 0.00% | +1,653 | New |
| Captrust Financial Advisors | 501 | $1.00K | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 334 | $484 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 191 | $0 | 0.00% | −3,985−95.4% | Reduced |
| North Star Investment Management Corp. | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 168 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 17 | $0 | 0.00% | +17 | New |
| Massmutual Trust Co FSB | 167 | $0 | 0.00% | +167 | New |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −10,404−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −594−100.0% | Sold out |